In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.

ASOP EU participated in the FAKECARE conference hosted by the Faculty of Law, University of Trento 17-18th December 2015. The conference brought together the team of “Project FAKECARE” comprising university researchers, supported by institutional actors and other relevant stakeholders, which had adopted a multidisciplinary and integrated approach (law, criminology, statistical and information science).

"It’s all fake" is the new message that the institute is seeking to promote in the next step of the nationwide campaign launched in France on 1 July 2015 through the dissemination of an information booklet to make people aware of the fake medicines available on internet that are also bought when travelling.

From 1st July online suppliers of medicines in the EU must be registered in the country they are operating.They also need to display on every page of their website offering medicines for sale, the new European common logo.

To mark this occasion a debate took place in the EU Parliament to raise awareness of the issue of patient safety and buying medicine online.

Despite the efforts of USP and other pharmacopeias to establish strong pharmaceutical quality standards worldwide, the problem of counterfeit medicines and the illegal online drug sellers that peddle these dangerous products is urgent and rampant.

Illegal Internet drug sellers often operate overseas, from countries such as Russia, China, India, Mauritius, and Turkey, and mask their identities to prevent detection by law enforcement. Many illegal drug sellers generate tens of millions of dollars annually—often avoiding prosecution by exploiting the global anonymity the Internet provides.

The Medicines and Healthcare products Regulatory Agency (MHRA) announced on June 18th that £15.8 million worth of counterfeit and unlicensed medicines and devices have been seized in the UK as part of a global operation.

The seizures are a result of a month-long international crackdown on the illegal internet trade of medical products that yielded £51.6 million worth of items from 115 different countries globally.

The Breakfast debate titled "Illegal sales of medicines over the Internet - how will the implementation of the Falsified Medicines Directive's Common Logo enhance patient safety?" will be held at the EU Parliament on July 2nd from 08:00 until 09:30.

It will be followed by the ASOP EU AGM Knowledge Sharing/Workshop at the Google Offices from 11:00 until 16:00.

The EAASM held a lunch debate in the European Parliament entitled “Managing healthcare costs: can patient safety be traded-off?”

The event addressed several issues of patient safety in the light of budget constraints in the healthcare sector during a discussion with the Members of the European Parliament and representatives of Pan-European organisations. It attracted over 25 people including a senior representative from DG Santé, MEPs, and their advisors, patient groups, the Industry trade sector.

The ​Falsified Medicines Directive's Common Logo promises to be a major step forward in the security of selling medicines at a distance and online. ASOP EU and its sister organisation's​, ASOP Global​ and CSIP​,​ will be fully supporting this initiative. To mark the launch of this support and the publication of ​ASOP EU​ position paper, ASOP ​Global​, ASOP EU and CSIP have a series of planned meeting with DG SANTE, Health Attaches ​of EU Member States​ and  directly with​ Member State ​officials ​who are ​responsible for the implementation of the Common Logo. These discussions are aptly timed, as the Common Logo must be implemented by July 2015.